GGrantIndex
← Leaderboards

Stephen R Marder

Va Greater Los Angeles Healthcare System

$9,815,519
Attributed
$9,865,144
Total exposure
11
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.3M · FY200625
$2.5M$1.9M$1.3M$625K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$9,865,144 · 9
VA$0 · 2

By mechanism

R01$4,397,447 · 2
N01$2,321,943 · 2
R33$1,865,993 · 1
R21$658,014 · 1
U01$311,880 · 1
P30$210,617 · 1

Top collaborators

Most similar at Va Greater Los Angeles Healthcare System

Same institution · by research overlap

Others in their field

Top investigators on “Schizophrenia

Research focus

SchizophreniaCommunitiesAntipsychotic AgentsClinical TrialsPharmaceutical PreparationsSkillsSocialClinical ResearchQuality Of LifeProgramsLinkMental Disorder ChemotherapyCognitionLongitudinal Human StudyHuman SubjectNeuropsychological TestsHuman Therapy EvaluationBehavioral /Social Science Research TagInnovationPsyche StructureGrantBaseDesignAward

Grant awards (26)

Enhancing Community Integration for Homeless Veterans$0
I50 · FY2025 · VA
Enhancing Community Integration for Homeless Veterans$0
I50 · FY2024 · VA
Enhancing Community Integration for Homeless Veterans$0
I50 · FY2023 · VA
Enhancing Community Integration for Homeless Veterans$0
I50 · FY2022 · VA
Enhancing Community Integration for Homeless Veterans$0
I50 · FY2021 · VA
Enhancing Community Integration for Homeless Veterans$0
I50 · FY2020 · VA
Enhancing Social Cognitive Training with Oxytocin: Linking Target Engagement to Clinical Effects$622,949
R33 · FY2019 · MH · contact PI
Enhancing Social Cognitive Training with Oxytocin: Linking Target Engagement to Clinical Effects$622,949
R33 · FY2018 · MH · contact PI
Enhancing Social Cognitive Training with Oxytocin: Linking Target Engagement to Clinical Effects$620,095
R33 · FY2017 · MH · contact PI
Enhancing Social Cognitive Training with Oxytocin: Linking Target Engagement to Clinical Effects$321,025
R21 · FY2016 · MH · contact PI
Enhancing Social Cognitive Training with Oxytocin: Linking Target Engagement to Clinical Effects$336,989
R21 · FY2015 · MH · contact PI
Opportunities for Innovative Drug Development for Schizophrenia$49,250
R13 · FY2010 · MH · contact PI
Opportunities for Innovative Drug Development for Schizophrenia$50,000
R13 · FY2009 · MH · contact PI
TREATMENT UNITS FOR RESEARCH ON NEUROCOGNITION & SCHIZOPHRENIA (TURNS)$2,321,943
N01 · FY2007 · MH · contact PI
Relapse Prevention: Long-Acting Atypical Antipsychotics$311,880
U01 · FY2006 · MH · contact PI
TREATMENT UNITS FOR RESEARCH ON NEUROCOGNITION AND SCHIZOPHRENIA /TURN-278041003$0
N01 · FY2006 · MH · contact PI
MANAGEMENT FOR RISK OF RELAPSE IN SCHIZOPHRENIA$547,795
R01 · FY2004 · MH
MANAGEMENT FOR RISK OF RELAPSE IN SCHIZOPHRENIA$671,351
R01 · FY2003 · MH
TREATMENT OF NEGATIVE SYMPTOMS &COGNITIVE IMPAIRMENTS$354,767
R01 · FY2003 · MH
MANAGEMENT FOR RISK OF RELAPSE IN SCHIZOPHRENIA$704,471
R01 · FY2002 · MH
TREATMENT OF NEGATIVE SYMPTOMS &COGNITIVE IMPAIRMENTS$357,194
R01 · FY2002 · MH
MANAGEMENT FOR RISK OF RELAPSE IN SCHIZOPHRENIA$658,551
R01 · FY2001 · MH
TREATMENT OF NEGATIVE SYMPTOMS &COGNITIVE IMPAIRMENTS$334,345
R01 · FY2001 · MH
MANAGEMENT FOR RISK OF RELAPSE IN SCHIZOPHRENIA$515,225
R01 · FY2000 · MH
TREATMENT OF NEGATIVE SYMPTOMS &COGNITIVE IMPAIRMENTS$253,748
R01 · FY2000 · MH
CORE--PSYCHOPHARMACOLOGY LABORATORY$210,617
P30 · FY2000 · MH